| |
Selamectin against Pneumonyssoides caninum mites
 |
Pneumonyssoides caninum is a nasal mite which is occuring especially in Scandinavia. Ivermectin was found to be highly effective against those but is not licensed for dogs. Would the licensed avermectin selamectin be an effective alternative?
|
|
|
| |
In a laboratory study to evaluate the efficacy of selamectin for treatment of canine nasal mite infection, 12 purpose-bred beagles were experimentally infected with Pneumonyssoides caninum (P. caninum).
Six of the dogs were treated with selamectin applied to the skin of the back at dosages of 6 to 24 mg/kg for three times at 2-week intervals. The remaining six dogs were an untreated control group.
At necropsy 39 to 46 days after inoculation, no P. caninum mites were found in any of the treated dogs. In contrast, nasal mites were found in five of the untreated dogs. This difference was statistically significant at P=0.015.
Source: Lotta Gunnarsson, Göran Zakrisson, Dan Christensson, Arvid Uggla (2004): Efficacy of Selamectin in the Treatment of Nasal Mite (Pneumonyssoides caninum) Infection in Dogs. In:
Journal of the American Animal Hospital Association 40:400-404 (2004)
Tell a friend
|
Print version
|
Send this article
|
| |
25th FECAVA EuroCongress 4-9 September 2019, St. Petersburg / RussiaESVN-ECVN Symposium 2018ESAVSVetAgendaLab in Practice - Clinical PathologyEuropean Master of Small Animal Veterinary MedicineSEVC 2014ESAVS - Neuropathology & MRICongressMed 2014ACVIM 2014VetContact
|
